Drone industry is on pace for big Pentagon contracts. These stocks would benefit the most

President Trump requested $1.5 trillion for defense in FY2027 (44% above FY2026); Needham estimates $63 billion of that could target unmanned/drone technology, including ~$55 billion for the Defense Autonomous Weapons Group. Needham names AeroVironment ($400 price target, ~+114% upside), Ondas ($23 PT, ~+141%), Karman ($125 PT, ~+50%) and Amprius ($20 PT, ~+20%) as potential beneficiaries. Impact is sector-positive but contingent on Congressional approval.

Analysis

The proposed defense funding surge reconfigures competitive dynamics away from a primacy of legacy platforms toward scaleable, high-volume unmanned production — favouring firms that can industrialize manufacturing, secure critical components, and demonstrate rapid iteration. That elevates the importance of upstream suppliers (power cells, RF semiconductors, high-efficiency motors, GaN amplifiers) and low-latency comms stacks; firms owning scarce IP in those niches should see margin expansion, while bespoke integrators that lack captive supply risk being squeezed on price and delivery.

Second-order constraints will be supply-side: battery cell throughput, specialized substrates, and qualification cycles for military-grade parts will likely bottleneck ramp timelines and compress near-term margins across the ecosystem. Expect meaningful bifurcation between companies that can deploy captive or long-term contracted supply (stable gross margins) versus those forced into spot-market purchases (margin volatility), with effects realized within 6–24 months as awards move from prototyping to production blocks.

Political and technical tail risks are non-trivial — appropriation changes, program re-scopes, export-control friction, or high-profile field failures could trigger swift revaluation; conversely, successful low-cost attritable drone deployments would accelerate procurement follow-through and aftermarket consumables revenue. That asymmetry argues for concentrated, time-boxed exposure to names with defensible manufacturing moats or rare component ownership, and for hedging around key program award timelines and congressional budget votes.

Key Decisions for Investors

• Long AVAV (high conviction): establish a 6–18 month directional position via stock or 1:1 long Jan-2027 LEAP calls sized to 2–3% portfolio risk. Rationale: direct product fit + existing contract footprint; hedge with 25% notional in short-dated puts keyed to appropriation headlines. Target: double on a confirmed multi-year procurement ramp; stop: -30% from entry on program cancellation signals.
• Long ONDS (moderate conviction): buy 9–12 month calls or a small-sized stock position to play Mistral integration optionality and comms/AI stack upside. Position size 1–2% portfolio; catalyst window is integration milestones and initial DoD follow-on awards. Risk/reward asymmetric if cross-selling to larger DoD programs materializes; downside is execution/M&A drag.
• Pairs and supply-chain plays: long KRMN (exposure to launchers) vs short a large legacy platform contractor that benefits less from attritable drones (size the short to neutralize market beta). Timeframe 6–24 months to capture procurement cadence; this isolates upside from small-systems demand while dampening macro defense beta.
• Selectively buy AMPX exposure via a conservative call spread (12–18 month) sized as a tactical carry trade (<=1% portfolio) — thesis depends on battery cell qualification and material pricing. Reward is capture of scarcity premia if long-range drone demand accelerates; risk is battery commoditization and longer-than-expected qualification timelines.
• Risk management: buy protection (puts) or allocate cash reserves around key congressional budget votes and initial DoD selection announcements (windows at ~3–9 months). Reduce directional size if DoD signals move spending toward R&D-only or off-shore supplier restrictions increase program friction.